Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,777 | 354 | 99.2% |
| Education | $54.54 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,020 | 51 | $0 (2024) |
| Lundbeck LLC | $880.97 | 49 | $0 (2024) |
| Allergan, Inc. | $784.10 | 46 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $519.59 | 28 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $507.77 | 27 | $0 (2024) |
| Alkermes, Inc. | $451.73 | 20 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $322.04 | 19 | $0 (2024) |
| Tris Pharma Inc | $291.61 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $224.26 | 9 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $169.23 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,301 | 59 | Takeda Pharmaceuticals U.S.A., Inc. ($143.94) |
| 2023 | $499.90 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($68.42) |
| 2020 | $342.46 | 17 | Otsuka America Pharmaceutical, Inc. ($69.34) |
| 2019 | $1,344 | 72 | Allergan Inc. ($226.54) |
| 2018 | $1,700 | 92 | Otsuka America Pharmaceutical, Inc. ($433.08) |
| 2017 | $1,644 | 91 | Lundbeck LLC ($304.58) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $54.54 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $25.66 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.44 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Central Nervous System | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: ADHD | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Neurology | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Neuropsychiatry | ||||||
| 08/27/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: ANTI-ANXIETY | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Neuroscience | ||||||
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 60 | 340 | $43,775 | $24,487 |
| 2022 | 2 | 46 | 236 | $32,425 | $19,022 |
| 2021 | 2 | 38 | 195 | $24,200 | $12,228 |
| 2020 | 2 | 38 | 209 | $23,500 | $11,452 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 153 | $22,950 | $15,822 | 68.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 24 | 153 | $19,125 | $8,269 | 43.2% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2023 | 12 | 34 | $1,700 | $395.54 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 117 | $17,550 | $12,346 | 70.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 23 | 119 | $14,875 | $6,677 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 88 | $10,825 | $6,144 | 56.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 19 | 107 | $13,375 | $6,084 | 45.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 19 | 104 | $13,000 | $5,833 | 44.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 105 | $10,500 | $5,619 | 53.5% |
About Dr. Aura-Marie Pawley, M.D
Dr. Aura-Marie Pawley, M.D is a Neurology healthcare provider based in San Marino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639207400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aura-Marie Pawley, M.D has received a total of $6,832 in payments from pharmaceutical and medical device companies, with $1,301 received in 2024. These payments were reported across 355 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,777).
As a Medicare-enrolled provider, Pawley has provided services to 182 Medicare beneficiaries, totaling 980 services with total Medicare billing of $67,189. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location San Marino, CA
- Active Since 03/01/2007
- Last Updated 11/26/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1639207400
Products in Payments
- REXULTI (Drug) $1,212
- VRAYLAR (Drug) $825.44
- LATUDA (Drug) $519.59
- TRINTELLIX (Drug) $479.09
- ABILIFY MAINTENA (Drug) $397.49
- ARISTADA (Drug) $289.41
- Trintellix (Drug) $277.08
- Dyanavel XR (Drug) $206.33
- NUEDEXTA (Drug) $184.02
- AUSTEDO (Drug) $165.35
- Aristada 441 mg (Drug) $162.32
- INVEGA SUSTENNA (Drug) $157.32
- Adzenys XR-ODT (Drug) $154.15
- JORNAY PM (Drug) $139.59
- BELSOMRA (Drug) $130.04
- Auvelity (Drug) $126.81
- INGREZZA (Drug) $124.54
- CAPLYTA (Drug) $121.05
- HETLIOZ (Drug) $118.20
- Austedo XR (Drug) $110.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.